世界の糖尿病性神経障害治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Diabetic Neurological Disorder Therapeutic Drug Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4124
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、100ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、糖尿病性神経障害治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（カプセル、ピル、その他）、用途別市場規模（対称性神経障害、焦点＆多巣性神経障害）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・糖尿病性神経障害治療薬の市場動向
・企業の競争状況、市場シェア
・糖尿病性神経障害治療薬の種類別市場規模と予測2016-2027（カプセル、ピル、その他）
・糖尿病性神経障害治療薬の用途別市場規模と予測2016-2027（対称性神経障害、焦点＆多巣性神経障害）
・糖尿病性神経障害治療薬の北米市場規模2016-2027（アメリカ、カナダ）
・糖尿病性神経障害治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・糖尿病性神経障害治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・糖尿病性神経障害治療薬の中南米市場規模2016-2027（メキシコ、ブラジル）
・糖尿病性神経障害治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（AstraZeneca、Johnson & Johnson、Takeda、Mitsubishi Chemical、Avanir Pharmaceuticals、Dong-A Pharmaceutical Co., Ltd.、Immune Pharmaceuticals、MediciNova、Sangamo BioSciences）
・結論

A drug used to treat mental illness caused by diabetes

Market Analysis and Insights: Global Diabetic Neurological Disorder Therapeutic Drug Market
The global Diabetic Neurological Disorder Therapeutic Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Diabetic Neurological Disorder Therapeutic Drug market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Diabetic Neurological Disorder Therapeutic Drug market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Diabetic Neurological Disorder Therapeutic Drug market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Diabetic Neurological Disorder Therapeutic Drug market.

Global Diabetic Neurological Disorder Therapeutic Drug Scope and Market Size
Diabetic Neurological Disorder Therapeutic Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Diabetic Neurological Disorder Therapeutic Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Capsule
Pills
Other

Segment by Application
Symmetrical Neuropathy
Focal and Multifocal Neuropathy

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
AstraZeneca
Johnson & Johnson
Takeda
Mitsubishi Chemical
Avanir Pharmaceuticals
Dong-A Pharmaceutical Co., Ltd.
Immune Pharmaceuticals
MediciNova
Sangamo BioSciences

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Diabetic Neurological Disorder Therapeutic Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Capsule
1.2.3 Pills
1.2.4 Other
1.3 Market by Application
1.3.1 Global Diabetic Neurological Disorder Therapeutic Drug Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Symmetrical Neuropathy
1.3.3 Focal and Multifocal Neuropathy
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Diabetic Neurological Disorder Therapeutic Drug Market Perspective (2016-2027)
2.2 Diabetic Neurological Disorder Therapeutic Drug Growth Trends by Regions
2.2.1 Diabetic Neurological Disorder Therapeutic Drug Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Diabetic Neurological Disorder Therapeutic Drug Historic Market Share by Regions (2016-2021)
2.2.3 Diabetic Neurological Disorder Therapeutic Drug Forecasted Market Size by Regions (2022-2027)
2.3 Diabetic Neurological Disorder Therapeutic Drug Industry Dynamic
2.3.1 Diabetic Neurological Disorder Therapeutic Drug Market Trends
2.3.2 Diabetic Neurological Disorder Therapeutic Drug Market Drivers
2.3.3 Diabetic Neurological Disorder Therapeutic Drug Market Challenges
2.3.4 Diabetic Neurological Disorder Therapeutic Drug Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Diabetic Neurological Disorder Therapeutic Drug Players by Revenue
3.1.1 Global Top Diabetic Neurological Disorder Therapeutic Drug Players by Revenue (2016-2021)
3.1.2 Global Diabetic Neurological Disorder Therapeutic Drug Revenue Market Share by Players (2016-2021)
3.2 Global Diabetic Neurological Disorder Therapeutic Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Diabetic Neurological Disorder Therapeutic Drug Revenue
3.4 Global Diabetic Neurological Disorder Therapeutic Drug Market Concentration Ratio
3.4.1 Global Diabetic Neurological Disorder Therapeutic Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Diabetic Neurological Disorder Therapeutic Drug Revenue in 2020
3.5 Diabetic Neurological Disorder Therapeutic Drug Key Players Head office and Area Served
3.6 Key Players Diabetic Neurological Disorder Therapeutic Drug Product Solution and Service
3.7 Date of Enter into Diabetic Neurological Disorder Therapeutic Drug Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Diabetic Neurological Disorder Therapeutic Drug Breakdown Data by Type
4.1 Global Diabetic Neurological Disorder Therapeutic Drug Historic Market Size by Type (2016-2021)
4.2 Global Diabetic Neurological Disorder Therapeutic Drug Forecasted Market Size by Type (2022-2027)

5 Diabetic Neurological Disorder Therapeutic Drug Breakdown Data by Application
5.1 Global Diabetic Neurological Disorder Therapeutic Drug Historic Market Size by Application (2016-2021)
5.2 Global Diabetic Neurological Disorder Therapeutic Drug Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Diabetic Neurological Disorder Therapeutic Drug Market Size (2016-2027)
6.2 North America Diabetic Neurological Disorder Therapeutic Drug Market Size by Type
6.2.1 North America Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2016-2021)
6.2.2 North America Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2022-2027)
6.2.3 North America Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2016-2027)
6.3 North America Diabetic Neurological Disorder Therapeutic Drug Market Size by Application
6.3.1 North America Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2016-2021)
6.3.2 North America Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2022-2027)
6.3.3 North America Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2016-2027)
6.4 North America Diabetic Neurological Disorder Therapeutic Drug Market Size by Country
6.4.1 North America Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2016-2021)
6.4.2 North America Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Diabetic Neurological Disorder Therapeutic Drug Market Size (2016-2027)
7.2 Europe Diabetic Neurological Disorder Therapeutic Drug Market Size by Type
7.2.1 Europe Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2016-2021)
7.2.2 Europe Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2022-2027)
7.2.3 Europe Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2016-2027)
7.3 Europe Diabetic Neurological Disorder Therapeutic Drug Market Size by Application
7.3.1 Europe Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2016-2021)
7.3.2 Europe Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2022-2027)
7.3.3 Europe Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2016-2027)
7.4 Europe Diabetic Neurological Disorder Therapeutic Drug Market Size by Country
7.4.1 Europe Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2016-2021)
7.4.2 Europe Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Diabetic Neurological Disorder Therapeutic Drug Market Size (2016-2027)
8.2 Asia-Pacific Diabetic Neurological Disorder Therapeutic Drug Market Size by Type
8.2.1 Asia-Pacific Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2016-2027)
8.3 Asia-Pacific Diabetic Neurological Disorder Therapeutic Drug Market Size by Application
8.3.1 Asia-Pacific Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2016-2027)
8.4 Asia-Pacific Diabetic Neurological Disorder Therapeutic Drug Market Size by Region
8.4.1 Asia-Pacific Diabetic Neurological Disorder Therapeutic Drug Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Diabetic Neurological Disorder Therapeutic Drug Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size (2016-2027)
9.2 Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size by Type
9.2.1 Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2016-2021)
9.2.2 Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2022-2027)
9.2.3 Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2016-2027)
9.3 Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size by Application
9.3.1 Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2016-2021)
9.3.2 Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2022-2027)
9.3.3 Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2016-2027)
9.4 Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size by Country
9.4.1 Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2016-2021)
9.4.2 Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Size (2016-2027)
10.2 Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Size by Type
10.2.1 Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2016-2027)
10.3 Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Size by Application
10.3.1 Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2016-2027)
10.4 Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Size by Country
10.4.1 Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Details
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Diabetic Neurological Disorder Therapeutic Drug Introduction
11.1.4 AstraZeneca Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2016-2021)
11.1.5 AstraZeneca Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Diabetic Neurological Disorder Therapeutic Drug Introduction
11.2.4 Johnson & Johnson Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2016-2021)
11.2.5 Johnson & Johnson Recent Development
11.3 Takeda
11.3.1 Takeda Company Details
11.3.2 Takeda Business Overview
11.3.3 Takeda Diabetic Neurological Disorder Therapeutic Drug Introduction
11.3.4 Takeda Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2016-2021)
11.3.5 Takeda Recent Development
11.4 Mitsubishi Chemical
11.4.1 Mitsubishi Chemical Company Details
11.4.2 Mitsubishi Chemical Business Overview
11.4.3 Mitsubishi Chemical Diabetic Neurological Disorder Therapeutic Drug Introduction
11.4.4 Mitsubishi Chemical Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2016-2021)
11.4.5 Mitsubishi Chemical Recent Development
11.5 Avanir Pharmaceuticals
11.5.1 Avanir Pharmaceuticals Company Details
11.5.2 Avanir Pharmaceuticals Business Overview
11.5.3 Avanir Pharmaceuticals Diabetic Neurological Disorder Therapeutic Drug Introduction
11.5.4 Avanir Pharmaceuticals Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2016-2021)
11.5.5 Avanir Pharmaceuticals Recent Development
11.6 Dong-A Pharmaceutical Co., Ltd.
11.6.1 Dong-A Pharmaceutical Co., Ltd. Company Details
11.6.2 Dong-A Pharmaceutical Co., Ltd. Business Overview
11.6.3 Dong-A Pharmaceutical Co., Ltd. Diabetic Neurological Disorder Therapeutic Drug Introduction
11.6.4 Dong-A Pharmaceutical Co., Ltd. Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2016-2021)
11.6.5 Dong-A Pharmaceutical Co., Ltd. Recent Development
11.7 Immune Pharmaceuticals
11.7.1 Immune Pharmaceuticals Company Details
11.7.2 Immune Pharmaceuticals Business Overview
11.7.3 Immune Pharmaceuticals Diabetic Neurological Disorder Therapeutic Drug Introduction
11.7.4 Immune Pharmaceuticals Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2016-2021)
11.7.5 Immune Pharmaceuticals Recent Development
11.8 MediciNova
11.8.1 MediciNova Company Details
11.8.2 MediciNova Business Overview
11.8.3 MediciNova Diabetic Neurological Disorder Therapeutic Drug Introduction
11.8.4 MediciNova Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2016-2021)
11.8.5 MediciNova Recent Development
11.9 Sangamo BioSciences
11.9.1 Sangamo BioSciences Company Details
11.9.2 Sangamo BioSciences Business Overview
11.9.3 Sangamo BioSciences Diabetic Neurological Disorder Therapeutic Drug Introduction
11.9.4 Sangamo BioSciences Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2016-2021)
11.9.5 Sangamo BioSciences Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Diabetic Neurological Disorder Therapeutic Drug Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Capsule
Table 3. Key Players of Pills
Table 4. Key Players of Other
Table 5. Global Diabetic Neurological Disorder Therapeutic Drug Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Diabetic Neurological Disorder Therapeutic Drug Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Diabetic Neurological Disorder Therapeutic Drug Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Diabetic Neurological Disorder Therapeutic Drug Market Share by Regions (2016-2021)
Table 9. Global Diabetic Neurological Disorder Therapeutic Drug Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Diabetic Neurological Disorder Therapeutic Drug Market Share by Regions (2022-2027)
Table 11. Diabetic Neurological Disorder Therapeutic Drug Market Trends
Table 12. Diabetic Neurological Disorder Therapeutic Drug Market Drivers
Table 13. Diabetic Neurological Disorder Therapeutic Drug Market Challenges
Table 14. Diabetic Neurological Disorder Therapeutic Drug Market Restraints
Table 15. Global Diabetic Neurological Disorder Therapeutic Drug Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Diabetic Neurological Disorder Therapeutic Drug Market Share by Players (2016-2021)
Table 17. Global Top Diabetic Neurological Disorder Therapeutic Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diabetic Neurological Disorder Therapeutic Drug as of 2020)
Table 18. Ranking of Global Top Diabetic Neurological Disorder Therapeutic Drug Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Diabetic Neurological Disorder Therapeutic Drug Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Diabetic Neurological Disorder Therapeutic Drug Product Solution and Service
Table 22. Date of Enter into Diabetic Neurological Disorder Therapeutic Drug Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Diabetic Neurological Disorder Therapeutic Drug Revenue Market Share by Type (2016-2021)
Table 26. Global Diabetic Neurological Disorder Therapeutic Drug Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Diabetic Neurological Disorder Therapeutic Drug Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Diabetic Neurological Disorder Therapeutic Drug Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Diabetic Neurological Disorder Therapeutic Drug Revenue Market Share by Application (2016-2021)
Table 30. Global Diabetic Neurological Disorder Therapeutic Drug Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Diabetic Neurological Disorder Therapeutic Drug Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Diabetic Neurological Disorder Therapeutic Drug Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Diabetic Neurological Disorder Therapeutic Drug Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2022-2027) & (US$ Million)
Table 62. AstraZeneca Company Details
Table 63. AstraZeneca Business Overview
Table 64. AstraZeneca Diabetic Neurological Disorder Therapeutic Drug Product
Table 65. AstraZeneca Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2016-2021) & (US$ Million)
Table 66. AstraZeneca Recent Development
Table 67. Johnson & Johnson Company Details
Table 68. Johnson & Johnson Business Overview
Table 69. Johnson & Johnson Diabetic Neurological Disorder Therapeutic Drug Product
Table 70. Johnson & Johnson Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2016-2021) & (US$ Million)
Table 71. Johnson & Johnson Recent Development
Table 72. Takeda Company Details
Table 73. Takeda Business Overview
Table 74. Takeda Diabetic Neurological Disorder Therapeutic Drug Product
Table 75. Takeda Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2016-2021) & (US$ Million)
Table 76. Takeda Recent Development
Table 77. Mitsubishi Chemical Company Details
Table 78. Mitsubishi Chemical Business Overview
Table 79. Mitsubishi Chemical Diabetic Neurological Disorder Therapeutic Drug Product
Table 80. Mitsubishi Chemical Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2016-2021) & (US$ Million)
Table 81. Mitsubishi Chemical Recent Development
Table 82. Avanir Pharmaceuticals Company Details
Table 83. Avanir Pharmaceuticals Business Overview
Table 84. Avanir Pharmaceuticals Diabetic Neurological Disorder Therapeutic Drug Product
Table 85. Avanir Pharmaceuticals Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2016-2021) & (US$ Million)
Table 86. Avanir Pharmaceuticals Recent Development
Table 87. Dong-A Pharmaceutical Co., Ltd. Company Details
Table 88. Dong-A Pharmaceutical Co., Ltd. Business Overview
Table 89. Dong-A Pharmaceutical Co., Ltd. Diabetic Neurological Disorder Therapeutic Drug Product
Table 90. Dong-A Pharmaceutical Co., Ltd. Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2016-2021) & (US$ Million)
Table 91. Dong-A Pharmaceutical Co., Ltd. Recent Development
Table 92. Immune Pharmaceuticals Company Details
Table 93. Immune Pharmaceuticals Business Overview
Table 94. Immune Pharmaceuticals Diabetic Neurological Disorder Therapeutic Drug Product
Table 95. Immune Pharmaceuticals Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2016-2021) & (US$ Million)
Table 96. Immune Pharmaceuticals Recent Development
Table 97. MediciNova Company Details
Table 98. MediciNova Business Overview
Table 99. MediciNova Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2016-2021) & (US$ Million)
Table 100. MediciNova Recent Development
Table 101. Sangamo BioSciences Company Details
Table 102. Sangamo BioSciences Business Overview
Table 103. Sangamo BioSciences Diabetic Neurological Disorder Therapeutic Drug Product
Table 104. Sangamo BioSciences Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2016-2021) & (US$ Million)
Table 105. Sangamo BioSciences Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Diabetic Neurological Disorder Therapeutic Drug Market Share by Type: 2020 VS 2027
Figure 2. Capsule Features
Figure 3. Pills Features
Figure 4. Other Features
Figure 5. Global Diabetic Neurological Disorder Therapeutic Drug Market Share by Application: 2020 VS 2027
Figure 6. Symmetrical Neuropathy Case Studies
Figure 7. Focal and Multifocal Neuropathy Case Studies
Figure 8. Diabetic Neurological Disorder Therapeutic Drug Report Years Considered
Figure 9. Global Diabetic Neurological Disorder Therapeutic Drug Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Diabetic Neurological Disorder Therapeutic Drug Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Diabetic Neurological Disorder Therapeutic Drug Market Share by Regions: 2020 VS 2027
Figure 12. Global Diabetic Neurological Disorder Therapeutic Drug Market Share by Regions (2022-2027)
Figure 13. Global Diabetic Neurological Disorder Therapeutic Drug Market Share by Players in 2020
Figure 14. Global Top Diabetic Neurological Disorder Therapeutic Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diabetic Neurological Disorder Therapeutic Drug as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Diabetic Neurological Disorder Therapeutic Drug Revenue in 2020
Figure 16. Global Diabetic Neurological Disorder Therapeutic Drug Revenue Market Share by Type (2016-2021)
Figure 17. Global Diabetic Neurological Disorder Therapeutic Drug Revenue Market Share by Type (2022-2027)
Figure 18. North America Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Diabetic Neurological Disorder Therapeutic Drug Market Share by Type (2016-2027)
Figure 20. North America Diabetic Neurological Disorder Therapeutic Drug Market Share by Application (2016-2027)
Figure 21. North America Diabetic Neurological Disorder Therapeutic Drug Market Share by Country (2016-2027)
Figure 22. United States Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Diabetic Neurological Disorder Therapeutic Drug Market Share by Type (2016-2027)
Figure 26. Europe Diabetic Neurological Disorder Therapeutic Drug Market Share by Application (2016-2027)
Figure 27. Europe Diabetic Neurological Disorder Therapeutic Drug Market Share by Country (2016-2027)
Figure 28. Germany Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Diabetic Neurological Disorder Therapeutic Drug Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Diabetic Neurological Disorder Therapeutic Drug Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Diabetic Neurological Disorder Therapeutic Drug Market Share by Region (2016-2027)
Figure 38. China Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Diabetic Neurological Disorder Therapeutic Drug Market Share by Type (2016-2027)
Figure 46. Latin America Diabetic Neurological Disorder Therapeutic Drug Market Share by Application (2016-2027)
Figure 47. Latin America Diabetic Neurological Disorder Therapeutic Drug Market Share by Country (2016-2027)
Figure 48. Mexico Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Share by Country (2016-2027)
Figure 54. Turkey Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. AstraZeneca Revenue Growth Rate in Diabetic Neurological Disorder Therapeutic Drug Business (2016-2021)
Figure 58. Johnson & Johnson Revenue Growth Rate in Diabetic Neurological Disorder Therapeutic Drug Business (2016-2021)
Figure 59. Takeda Revenue Growth Rate in Diabetic Neurological Disorder Therapeutic Drug Business (2016-2021)
Figure 60. Mitsubishi Chemical Revenue Growth Rate in Diabetic Neurological Disorder Therapeutic Drug Business (2016-2021)
Figure 61. Avanir Pharmaceuticals Revenue Growth Rate in Diabetic Neurological Disorder Therapeutic Drug Business (2016-2021)
Figure 62. Dong-A Pharmaceutical Co., Ltd. Revenue Growth Rate in Diabetic Neurological Disorder Therapeutic Drug Business (2016-2021)
Figure 63. Immune Pharmaceuticals Revenue Growth Rate in Diabetic Neurological Disorder Therapeutic Drug Business (2016-2021)
Figure 64. MediciNova Revenue Growth Rate in Diabetic Neurological Disorder Therapeutic Drug Business (2016-2021)
Figure 65. Sangamo BioSciences Revenue Growth Rate in Diabetic Neurological Disorder Therapeutic Drug Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

以下、関連資料のご紹介

世界の神経疾患診断市場規模・現状・予測（2021年-2027年）

Global Neurological Disorder Diagnostics Market Size, Status and Forecast 2021-2027
QFJ1-4569 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、神経疾患診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（イメージング技術、体外診断技術）、用途別市場規模（病院・クリニック、診断センター、外来診療センター）、主要地域別市場規模（北米、アメリカ、欧...

世界の糖尿病性足潰瘍治療薬市場規模・現状・予測（2021年-2027年）

Global Diabetic Foot Ulcer Therapeutic Market Size, Status and Forecast 2021-2027
QFJ1-4122 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、糖尿病性足潰瘍治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（事前創傷被覆材、代用皮膚、陰圧閉鎖療法装置）、用途別市場規模（病院、専門クリニック、介護センター、外来外科センター）、主要地域別市場...

世界の不安障害＆うつ病治療薬市場規模・現状・予測（2021年-2027年）

Global Anxiety Disorders And Depression Therapeutic Drug Market Size, Status and Forecast 2021-2027
QFJ1-5593 2021年6月 118Pages
QYResearch社発行の本調査レポートでは、不安障害＆うつ病治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（SSRI、SNRI、TeCA、TCA、MAOI、非定型抗精神病薬、ベンゾジアゼピン、抗けいれん薬、ベータ遮断薬、その他）、用途別市...

世界の抗凝固治療薬モニタリングアッセイキット市場規模・現状・予測（2021年-2027年）

Global Anticoagulant Therapeutic Drug Monitoring Assay Kit Market Size, Status and Forecast 2021-2027
QFJ1-3824 2021年6月 87Pages
QYResearch社発行の本調査レポートでは、抗凝固治療薬モニタリングアッセイキットの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（蛍光偏光免疫測定法、均一酵素免疫測定法、酵素結合免疫吸着測定法）、用途別市場規模（病院、診療所、その他）、主要地域...

世界の副鼻腔治療薬市場規模・現状・予測（2021年-2027年）

Global Sinus Therapeutic Drug Market Size, Status and Forecast 2021-2027
QFJ1-4863 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、副鼻腔治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、局所、注射）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国...

世界のB型肝炎用治療薬市場規模・現状・予測（2021年-2027年）

Global Hepatitis B Therapeutic Drug Market Size, Status and Forecast 2021-2027
QFJ1-5777 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、B型肝炎用治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（エンテカビル、テノホビル、ラミブジン、アデフォビル、テルビブジン、その他）、用途別市場規模（病院薬局、小売薬局＆ドラッグストア、その他）...

世界の核医学治療薬市場規模・現状・予測（2021年-2027年）

Global Nuclear Drug for Therapeutic Market Size, Status and Forecast 2021-2027
QFJ1-5899 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、核医学治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ラジウム-223、ルテチウム-177、ヨウ素-131、その他）、用途別市場規模（甲状腺、骨転移、リンパ腫、その他）、主要地域別市場規模（北米...

世界の核医療治療薬市場規模・現状・予測（2021年-2027年）

Global Therapeutic Nuclear Drug Market Size, Status and Forecast 2021-2027
QFJ1-6035 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、核医療治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ラジウム-223、ルテチウム-177、ヨウ素-131、その他）、用途別市場規模（甲状腺、骨転移、リンパ腫、その他）、主要地域別市場規模（北米...

世界のアミノ酸代謝異常症薬市場規模・現状・予測（2021年-2027年）

Global Amino Acid Metabolism Disorder Drug Market Size, Status and Forecast 2021-2027
QFJ1-5575 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、アミノ酸代謝異常症薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アルギニン、葉酸、ビタミンB6＆B12、チアミン、ビタミンD、ベタイン、カルグルミン酸、二塩酸塩サプロプテリン、その他）、用途別市場...

世界のグランツマン血小板無力症治療薬市場規模・現状・予測（2021年-2027年）

Global Glanzmann Thrombasthenia Therapeutic Drug Market Size, Status and Forecast 2021-2027
QFJ1-4257 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、グランツマン血小板無力症治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（血小板輸血、組換え活性化第VII因子、抗線溶薬、フィブリンシーラント、トロンビン、デスモプレシン）、用途別市場規模（病院、...

世界の神経疾患診断市場規模・現状・予測（2021年-2027年） Neurological disorders diagnostic tools are tools used to diagnose various neurological disorders. Market Analysis and Insights: Global Neurological Disorder Diagnostics Market The global Neurological Disorder Diagnostics market size is projected to reach US$ 13800 million by 2027, from US$ 10080 mi…
世界の糖尿病性足潰瘍治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Diabetic Foot Ulcer Therapeutic Market The global Diabetic Foot Ulcer Therapeutic market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data i…
神経疾患診断のグローバル市場：規模・現状・予測2019-2025 Neurological disorders diagnostic tools are tools used to diagnose various neurological disorders.In 2018, the global Neurological Disorder Diagnostics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focus…
神経疾患診断のグローバル市場：規模・現状・予測2019-2025 Neurological disorders diagnostic tools are tools used to diagnose various neurological disorders.In 2018, the global Neurological Disorder Diagnostics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focus…
世界の不安障害＆うつ病治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Anxiety Disorders And Depression Therapeutic Drug Market The global Anxiety Disorders And Depression Therapeutic Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard …